Sulforaphane as an adjunctive to everolimus counteracts everolimus resistance in renal cancer cell lines

Juengel, E; Euler, S; Maxeiner, S; Rutz, J; Justin, S; Roos, F; Khoder, W; Nelson, K; Bechstein, WO; Blaheta, RA

Blaheta, RA (reprint author), Goethe Univ, Dept Urol, Interdisciplinary Sci Bldg,Bldg 25A,Room 404, D-60590 Frankfurt, Germany.

PHYTOMEDICINE, 2017; 27 ( ): 1

Abstract

Background: The mechanistic target of rapamycin (mTOR) inhibitors, everolimus and temsirolimus, have widened therapeutic options to treat renal cell c......

Full Text Link